Persistent clinical proteinuria (i.e., urinary protein excretion >0.5 g/24 h) is an ominous development in a person with diabetes. It eventually leads to a decline in the glomerular filtration rate and ultimately to end-stage renal failure or premature cardiovascular mortality. Progression of renal disease appears to be related to arterial blood pressure and protein intake and is primarily independent of the metabolic state. More sensitive immunoassays for detecting low concentrations of albumin in urine have led to recognition of subclinical increases in albumin excretion rates in nonclinically proteinuric diabetic patients, a phenomenon named microalbuminuria. Studies have shown that patients with microalbuminuria have a significantly increased risk for clinical proteinuria and cardiovascular mortality. Microalbuminuria is rarely found during the first 5 yr of a patient's diabetes, suggesting that it is a sign of early glomerular damage rather than a marker for susceptibility to it. In patients with non-insulin-dependent diabetes mellitus (NIDDM), an association has been found between microalbuminuria and coronary heart disease, but this relationship needs further investigation. In patients with insulin-dependent diabetes mellitus (IDDM), this subclinical form of proteinuria is associated with poor metabolic control and, more important, with marginal elevation of blood pressure. Correction of hyperglycemia by intensified insulin treatment might arrest progression to persistent clinical proteinuria; moreover, restricted protein intake and lowering of blood pressure have been shown to reduce the albumin excretion rate. Recent evidence suggests that the development of nephropathy in IDDM may be linked to a familial, possibly genetically determined, predisposition to hypertension. The identification of genetic components would enable clinicians to focus therapy on patients at risk for development of diabetic nephropathy. Diabetes Care 11: 1988 
C
linical proteinuria is generally defined as a total urinary protein excretion >0.5 g/24 h. The appearance of proteinuria in a diabetic patient marks a phase that ultimately leads to end-stage renal failure or premature mortality, usually from coronary artery disease (1) . Proteinuria develops in -35% of patients with insulin-dependent diabetes mellitus (IDDM) (2) and in an ill-defined but supposedly smaller proportion of -10% of patients of European origin with non-insulin-dependent diabetes mellitus (NIDDM). Large ethnic variations are seen in the incidence of diabetic nephropathy in NIDDM patients. A higher incidence is found in populations such as Japanese, Asian and American Indians, and Mexicans, who develop the disease at an early age. Some of these ethnic groups are somewhat protected from coronary heart disease, thus allowing time for the renal disease to manifest itself.
Because of the higher frequency of NIDDM in patients of European origin, approximately the same number of IDDM and NIDDM subjects develop end-stage renal failure. Diabetic kidney disease is rapidly becoming the single most common cause of end-stage renal failure; in some countries, diabetic patients represent up to onethird of all patients receiving renal support (3, 4) .
CHARACTERISTICS OF CLINICAL PROTEINURIA
The features of clinical proteinuria have been studied mostly in IDDM patients. Persistent proteinuria reaches G. VIBERT1 a peak incidence in patients who have had diabetes for an average of 16 yr (5) . The glomerular filtration rate (GFR) may be normal or even raised at the onset of persistent clinical proteinuria, but it will relentlessly fall, with a mean rate of decline of ~1 ml • min" 1 • mo" 1 . However, wide individual variations are seen. For a given patient, the fall appears linear with time, but the factors that determine the individual rates of decline are still largely unknown, although levels of blood pressure seem to contribute. Urinary protein excretion increases as GFR falls, and a highly significant negative correlation has been found between GFR and clearances of albumin and IgG (6) . The excretion of albumin correlates positively with the urinary total protein excretion; at the onset of persistent clinical proteinuria, albumin represents -50% of total urinary protein (7) .
Persistent proteinuria is primarily glomerular in origin. Tubular reabsorption capacity soon becomes completely saturated; changes in urinary excretion of plasma proteins thus become a more accurate reflection of changes in transglomerular transport. The urinary excretion rate of low-molecular-weight proteins, such as (3 2 -microglobulin or lysozyme, does not increase until glomerular function is markedly depressed and plasma levels of these proteins have risen. Saturation of the tubular reabsorptive capacity in functioning nephrons with protein overload can cause a rising urinary excretion rate rather than primary tubular dysfunction. The urinary clearance of f$ 2 -microglobulin rises exponentially when GFR falls below 40 ml/min.
The proteinuria of diabetic nephropathy is initially highly selective, with preferential filtration of anionic albumin until the GFR falls below 20 ml/min. At that stage, the clearance rate of neutral, larger IgG increases proportionately more than that of albumin, with the appearance of a low-selectivity proteinuria as GFR falls below 10 ml/min. The selectivity index, i.e., the ratio between the clearance of IgG and that of albumin, rises from 0.13 to 0.62 (7) . This loss of size selectivity of the glomerular filter in advanced diabetic nephropathy has been attributed, in a pathophysiological setting, to the appearance of large glomerular membrane defects (shunts) covering 1-2% of the total filtering surface area. These shunts allow ready filtration of large neutral macromolecules (8) . Thus, the proteinuria of diabetic nephropathy appears to be partly due to a loss of the charge-and size-restrictive properties of the glomerular membrane to filtration of plasma proteins. Disturbances of glomerular basement membrane glycosaminoglycans and glycosialoproteins, which have been described in diabetes, provide a structural biochemical basis for the increased filtration of protein (9) . Hemodynamic factors probably play an important role as well; intraglomerular hypertension is likely to develop in the surviving glomeruli, which become enlarged to compensate for the loss of sclerosed nephrons (10) . The reduction of proteinuria in response to control of systemic hypertension would support this view (11) .
CONCOMITANTS OF PERSISTENT PROTEINURIA
Persistent clinical proteinuria shows no relationship to the current level of diabetic control. Neither mean plasma glucose concentrations nor glycosylated hemoglobin (HbA 1c ) levels correlate significantly with clearance and excretion rates of different proteins (7) . An association between levels of HbA 1c and the rate of decline of GFR in IDDM patients with diabetic nephropathy has been claimed by some researchers but not confirmed by others (12) (13) (14) . Long-term correction of hyperglycemia by intensified insulin administration fails to stop the progressive rise in fractional clearance of albumin and IgG and does not significantly affect the rate of decline of the GFR in diabetic patients with renal railure (15) .
The interrelationship between arterial pressure and proteinuria is closer. Recent acute studies show that the urinary albumin excretion rate (AER) is partly dependent on blood pressure levels. Chronic vigorous treatment of raised blood pressure can check the progressive rise in the clearance of albumin. The rate of fall of the GFR is also slowed by antihypertensive treatment (11) . It is still unclear whether these effects result from a reduction of systemic blood pressure or a modification of intraglomerular pressure, as suggested by studies with angiotensin-converting enzyme inhibitors in which proteinuria was lowered without significant attendant changes in systemic arterial pressure (16, 17) .
The intraglomerular pressure hypothesis is supported by the results obtained by restricting dietary protein. A reduced protein intake, which in the diabetic rat model has been found to correct the intraglomerular hypertension of diabetes (18), has proved effective in reducing proteinuria in IDDM patients independent of blood pressure or blood glucose changes (19) . The low-protein diet reduces proteinuria by reducing the fractional clear- 
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ance of both albumin and IgG independent of measurable changes in GFR or renal plasma flow (20) . This finding does not exclude the possibility that changes in gomerular pressure, which may affect filtration of protein, may have occurred. These data suggest that in diabetic nephropathy, glomerular permselectivity and, in particular, size selectivity are affected by the amount of protein intake. Long-term reduction of dietary protein has proven effective in reducing the rate of fall of GFR. It appears, therefore, that the clinical proteinuria of diabetes is independent of the metabolic disturbance of diabetes but is affected, to a large extent, by blood pressure and the amount of protein in the diet. Table 1 summarizes the effect of blood glucose, blood pressure, and dietary protein on renal function in established diabetic nephropathy. The strong association between persistent proteinuria and progression to end-stage renal failure and the increased risk of premature cardiovascular mortality in proteinuric diabetic patients have prompted research into the early phases of renal involvement in diabetes in an attempt to discover predictors of clinical proteinuria.
SUBCLINICAL DIABETIC ALBUMINURIA
The definition of persistent clinical proteinuria depends on the sensitivity of the methods used to detect protein in urine. The use of immunoassays for detecting low concentrations of albumin in urine has demonstrated that diabetic patients may excrete albumin in the urine at the rate substantially above normal, and yet the rate may remain well below the usual clinical levels of detection (for review see ref. 21) . A significant increase in mean AER was demonstrated in recently diagnosed NIDDM subjects in a population survey. The AER in these patients was, on average, three to four times above normal. Similar elevations have been found in NIDDM patients with disease of some years' standing (22) . Elevated AERs have also been described in newly diagnosed children with IDDM and in shortterm IDDM patients after withdrawal of insulin for several days. In established adult IDDM patients, with disease duration ranging from 6 mo to 39 yr, increased AERs and IgG excretion rates have been reported in a substantial proportion, especially in those with diabetes duration of 10-20 yr.
DEFINITION OF MICROALBUMINURIA
The subclinical increases in urinary albumin have been termed microalbuminuria (7) . The use of this new term may occasionally generate confusion. The AER in healthy adults ranges between 2.5 and 26.0 mg/24 h, with a geometric mean of 9.5 mg/25 h. The amount of albumin in these subjects represents up to 11 % of total urinary protein. These levels of AER are defined as normoalbuminuria. Diabetic patients with urine positive to the dipstick test generally have AERs >250 mg/24 h, and albumin represents -50% of total urinary protein excretion. These levels are defined as persistent clinical albuminuria. A wide, subclinical range of albumin hyperexcretion may therefore occur in diabetic patients with negative dipstick-test results. These AERs, usually between 26 and 250 mg/24 h, exceed the normal range but fall short of detection by standard tests for proteinuria. Albumin in these patients may represent up to 22% of total urinary protein. AERs of this degree are defined as microalbuminuria (7) . AERs can vary due to the combined effects of concentration, urine flow, and the inherent day-to-day variability of albumin excretion of -40%. Because of this variability the AERs of patients near the cutoff point for different categories of albuminuria are more likely to be misclassified. Therefore, it is prudent to perform multiple collections before assigning patients to a specific category.
Small concentrations of albumin in the urine can be measured quantitatively by several methods (for review see ref. 21 ). Recently, a new qualitative agglutination inhibition test for urinary albumin at low concentration was developed. This method, specific for human albumin, is sensitive, simple, and easy to perform and may prove useful for screening purposes (23) .
CHARACTERISTICS OF MICROALBUMINURIA
In microalbuminuric diabetic subjects, the clearance rates of polyanionic albumin and neutral IgG are both increased. This microproteinuria is believed to be glomerular in origin because no convincing evidence indicates that the tubular reabsorptive capacity of proteins is impaired in adult IDDM patients under ordinary metabolic control. As microalbuminuria increases, the selectivity index starts to fall, reaching its lowest values of -0.13 when albumin excretion is -90 |xg/min or higher. This decrease is due to a disproportionate increase in the filtration of albumin compared with IgG, and it marks a new stage of selective glomerular loss of polyanionic albumin. Medium-sized pores are unchanged; a likely reason for the increased glomerular filtration of albumin is a loss of the fixed negative electrical charge on the glomerular membrane (7). This loss would permit increased permeation of anionic albumin but have little influence on IgG, a neutral molecule whose filtration is regulated by pore radius and number. The mechanism of this transition from low to high levels of microalbuminuria with the appearance of a charge-selectivity defect is unknown, but it may be the result of metabolically induced derangement of synthesis of the electronegative membrane proteoglycans (24) .
Glycosylation of structural and circulating proteins may also be important in this context. Microvessels isolated from rat epididymal fat preferentially take up glycosylated rat albumin by endocytosis; glycosylation of endothelial membrane components seems to further enhance this process. Two recent reports indicate that glycosylated albumin undergoes preferential transport across the glomerular membrane (25, 26) . The reason is unknown, but it is possible that conformational changes induced by glycosylation are a relevant factor. The transition to high-selectivity proteinuria signals the advent of heavier proteinuria and may indicate the critical importance of the loss of the charge barrier in the sequence of pathogenetic events.
ASSOCIATIONS OF MICROALBUMINURIA
The AER is -2 5 % higher during the day in the upright ambulant position than during the night in the recumbent position. Microalbuminuric patients tend to have a longer duration of diabetes, and a correlation between disease duration and AER has been described in patients with >5 yr of diabetes. In adult patients, age does not appear to relate to AER, and changes in urinary excretion of glucose do not acutely affect AER. In both IDDM and NIDDM patients, microalbuminuria has been reported in a preponderance of men (22, 27) . A transient increase in albumin excretion is seen in normal subjects after water loading, but this is likely to be mediated by transient changes in glomerular filtration. Urinary albumin excretion, although normal at rest, may show an exaggerated rise in response to moderately strenuous exercise. The severity of the exercise-induced albuminuria seems to be related to the duration of the diabetes and is modulated by the level of blood glucose control (7) .
In selected groups of IDDM patients, significant positive correlations have been found between average metabolic control of diabetes and AER. Prospective studies have shown that strict blood glucose control by intensified insulin treatment reduces the AER or prevents its further rise (28, 29) . Acute experimental induction of metabolic acidosis has no effect on urinary albumin excretion but increases the excretion of p 2 -microglobulin, suggesting a prime effect at the tubular level (30) . Infusion of insulin, glucagon, and growth hormone has no effect on urinary albumin excretion in normal or diabetic subjects (21). Protein intake is an important determinant of urinary albumin excretion, and a low-protein diet has proved effective in lowering albumin excretion in microalbuminuric IDDM patients (31) . Microalbuminuria is also associated with higher levels of arterial pressure. A positive, linear, and independent correlation between arterial pressure and AER has been confirmed by several investigations in IDDM subjects (21) .
Patients with AERs >30 |xg/min have mean systolic and diastolic blood pressures that are higher than those of a matched group of diabetic patients with lower AERs. Whether the higher blood pressures are a cause or an effect of the renal dysfunction or whether high blood pressure and microalbuminuria have a common determinant is unknown. At this stage, no hint of renal failure is apparent, and it is therefore difficult to view the elevation of blood pressure as simply a consequence of the renal hypofunction. Short-term studies have shown that a lowering of blood pressure induces a fall in microalbuminuria (32) .
In NIDDM patients, the AER is significantly associated with coronary heart disease morbidity, a relationship independent of the confounding effects of hypertension and other cardiovascular risk factors (22) . The association between microalbuminuria and coronary heart disease requires further investigation. Important ethnic differences in the prevalence of microalbuminuria have been described in NIDDM patients (33) ; patients of Asian Indian origin have higher rates or urinary albumin excretion than a comparable group of European NIDDM patients. Asian Indian diabetic patients have been found to have a higher prevalence of diabetic kidney disease.
PROGNOSTIC SIGNIFICANCE OF MICROALBUMINURIA
The connection between microalbuminuria and clinical nephropathy was demonstrated by three prospective studies of cohorts of IDDM patients. The results of these studies suggested the existence of an AER threshold above which the risk of progression to clinical proteinuria, and thus progressive decline of glomerular function, is increased (21) . The overall findings of these studies are remarkably similar; the difference in methods and length of follow-up were probably responsible for the different risk levels of AER. Diabetic patients with overnight or 24-h urinary AERs between 30 and 200 (xg/min have a 20 times greater risk of developing clinical nephropathy, whereas only 4% of diabetic patients with lower or normal AERs develop clinical nephropathy.
Recent evidence indicates that, after stabilization of newly diagnosed diabetes, supranormal levels of AERs are only rarely found in the first 5 yr of diabetes but become more frequent afterward (27) . These findings strongly suggest that microalbuminuria is a sign of early disease rather than a marker for susceptibility.
Two studies have also examined the prognostic value of microalbuminuria in cohorts of NIDDM subjects of European origin (34, 35) . Over an interval of 10-14 yr, both studies showed a significantly increased risk for cardiovascular mortality and clinical proteinuria in patients with subclinically elevated AERs. Table 2 illustrates the predictive values of microalbuminuria in five studies.
PREDISPOSITION TO MICROALBUMINURIA
The ominous prognostic significance of microalbuminuria necessitates identifying the subjects most likely to develop this condition. This problem has been explored primarily in the IDDM patient.
It is generally assumed that the elevation of blood pressure in diabetic nephropathy is a phenomenon secondary to the renal failure. However, the observations that elevated blood pressure is found in patients at risk for nephropathy who have perfectly maintained levels of glomerular function and that uncomplicated long-term diabetic survivors have relatively low pressures argue in favor of a more complex relationship (36, 37) . It is possible to postulate that the rise in arterial pressure could be contributory rather than secondary to renal disease or, alternatively, that proteinuria and hypertension may have a common determinant.
The hypothesis that a predisposition to raised arterial pressure may contribute to a susceptibility to renal disease was tested by measuring the arterial pressure in the parents of IDDM subjects with and without clinical proteinuria (38) . The groups were matched for age, sex, and body mass index, but blood pressure was significantly higher in the parents of the proteinuric patients than in the parents of the nonproteinuric patients (Table  3) . A strong correlation was seen between the arterial pressure of the proteinuric diabetic patients and that of their parents. Mortality among the parents was similar, thus making it unlikely that the differences between the groups arose as a consequence of selective removal of subjects by mortality. These data have been complemented by studies indicating that the erythrocyte sodium-lithium countertransport-a cell membrane transport system whose activity is associated with the risk of essential hypertension-is elevated in diabetic patients with either clinical proteinuria or microalbuminuria (39,40; Table 4 ). Evidence shows that the sodium-lithium countertransport aggregates in families and a large proportion of its activity is genetically determined, even though a number of environmental factors can further affect it. These findings taken together support the view that a familial predisposition to hypertension, probably genetically determined (even though environmental factors cannot be totally excluded), may be linked to the development of nephropathy when diabetes is present. Studies in families of proteinuric diabetic patients and prospective studies in normoalbuminuric diabetic patients with high sodium-lithium countertransport activity are needed to confirm the genetic nature and predictive value of this phenomenon.
The identification of the genetic components of diabetic nephropathy would make it easier to focus therapeutic measures on susceptible patients and would possibly lead to the development of new pharmacologic or other interventions.
